Franklin Resources’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-399,640
| Closed | -$68.8M | – | 2598 |
|
|
2021
Q3 | $68.8M | Sell |
399,640
-15,730
| -4% | -$2.06M | 0.03% | 558 |
|
|
2021
Q2 | $52.1M | Buy |
415,370
+7,638
| +2% | +$963K | 0.02% | 640 |
|
|
2021
Q1 | $55.3M | Buy |
407,732
+25,088
| +7% | +$3.24M | 0.02% | 592 |
|
|
2020
Q4 | $49M | Buy |
382,644
+132
| +0% | +$15.5K | 0.02% | 599 |
|
|
2020
Q3 | $43M | Buy |
+382,512
| New | +$38.1M | 0.02% | 588 |
|
|
2019
Q4 | – | Sell |
-346,477
| Closed | -$13.7M | – | 1592 |
|
|
2019
Q3 | $13.7M | Hold |
346,477
| – | – | 0.01% | 823 |
|
|
2019
Q2 | $14.2M | Sell |
346,477
-304,900
| -47% | -$12.6M | 0.01% | 823 |
|
|
2019
Q1 | $30.3M | Buy |
651,377
+108,838
| +20% | +$4.78M | 0.02% | 641 |
|
|
2018
Q4 | $23.6M | Buy |
542,539
+106,962
| +25% | +$5.34M | 0.01% | 660 |
|
|
2018
Q3 | $24.9M | Hold |
435,577
| – | – | 0.01% | 717 |
|
|
2018
Q2 | $21.1M | Hold |
435,577
| – | – | 0.01% | 763 |
|
|
2018
Q1 | $17M | Hold |
435,577
| – | – | 0.01% | 821 |
|
|
2017
Q4 | $18.5M | Sell |
435,577
-27,400
| -6% | -$1.03M | 0.01% | 815 |
|
|
2017
Q3 | $17.3M | Hold |
462,977
| – | – | 0.01% | 835 |
|
|
2017
Q2 | $14.1M | Sell |
462,977
-20,000
| -4% | -$580K | 0.01% | 882 |
|
|
2017
Q1 | $12.8M | Hold |
482,977
| – | – | 0.01% | 905 |
|
|
2016
Q4 | $12.3M | Sell |
482,977
-11,800
| -2% | -$374K | 0.01% | 908 |
|
|
2016
Q3 | $17.9M | Hold |
494,777
| – | – | 0.01% | 837 |
|
|
2016
Q2 | $16.8M | Hold |
494,777
| – | – | 0.01% | 849 |
|
|
2016
Q1 | $13.1M | Sell |
494,777
-423
| -0.1% | -$12.3K | 0.01% | 912 |
|
|
2015
Q4 | $24.1M | Sell |
495,200
-32,677
| -6% | -$1.18M | 0.01% | 778 |
|
|
2015
Q3 | $13.1M | Sell |
527,877
-6,700
| -1% | -$201K | 0.01% | 949 |
|
|
2015
Q2 | $16.9M | Buy |
534,577
+10,300
| +2% | +$332K | 0.01% | 924 |
|
|
2015
Q1 | $20M | Hold |
524,277
| – | – | 0.01% | 898 |
|
|
2014
Q4 | $20.4M | Sell |
524,277
-20,300
| -4% | -$707K | 0.01% | 869 |
|
|
2014
Q3 | $16.5M | Sell |
544,577
-112,800
| -17% | -$3.18M | 0.01% | 924 |
|
|
2014
Q2 | $22.3M | Sell |
657,377
-71,200
| -10% | -$2.38M | 0.01% | 837 |
|
|
2014
Q1 | $25.1M | Buy |
728,577
+132,000
| +22% | +$5.96M | 0.01% | 795 |
|
|
2013
Q4 | $23.6M | Buy |
+596,577
| New | +$14.4M | 0.01% | 762 |
|
Franklin Resources's XLRN Position: Q4 2021 in Review
Franklin Resources sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 399,640 shares — an estimated $68.8M sold.
Franklin Resources first reported a position in XLRN in Q4 2013 and held it in 29 quarters. The position peaked at $68.8M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.
- Franklin Resources reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
- Franklin Resources sold 399,640 Acceleron Pharma shares in Q4 2021, an estimated $68.8M.
- Franklin Resources first reported a position in Acceleron Pharma in Q4 2013 and held it in 29 quarters.
- Franklin Resources's Acceleron Pharma position peaked at $68.8M in Q3 2021.
- 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.
Based on Franklin Resources's 13F filing for Q4 2021, filed 11 Feb 2022.